Shareholders that lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK

Core Viewpoint - A class action securities lawsuit has been filed against Merck & Co., Inc. due to alleged securities fraud affecting investors between February 3, 2022, and February 3, 2025 [1] Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who were misled by the company's statements regarding expected revenue of $11 billion from Gardasil sales by 2030 [2] - Merck's optimistic forecasts were based on anticipated consumer activation and education efforts to drive demand for Gardasil, particularly in China [2] - The truth emerged on February 4, 2025, when Merck announced it would not achieve the projected $11 billion in sales and would halt shipments to China to reduce inventory, leading to a stock price drop of over 9% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until April 14, 2025, to request appointment as lead plaintiff, although participation does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions for shareholders and is recognized as a leading firm in securities litigation, with over 70 employees [4] - The firm has been ranked in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years [4]